by: Bemis, Guy W.; Salituro, Francesco Gerald; Duffy, John Patrick;

Inhibitors of p38

The present invention relates to inhibitors of p38, a mammalian protein kinase involved cell proliferation, cell death and response to extracellular stimuli. The invention also relates to methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing those compositions in the treatment and prevention of various disorders.






We claim:

1. A compound of the formula: ##STR38## wherein: each of Q.sub.1 and Q.sub.2 are independently selected from phenyl or pyridyl;

wherein:

Q.sub.1 is substituted with 1 to 4 substituents, independently selected from halo; C.sub.1 -C.sub.3 alkyl; C.sub.1 -C.sub.3 alkyl substituted with NR', OR', CO.sub.2 R' or CONR'.sub.2 ; O--(C.sub.1 -C.sub.3)-alkyl; O--(C.sub.1 -C.sub.3)-alkyl substituted with NR', OR', CO.sub.2 R' or CONR'.sub.2 ; NR'.sub.2 ; OCF.sub.3 ; CF.sub.3 ; NO.sub.2 ; CO.sub.2 R'; CONR'; SR'; SCF.sub.3 ; or CN; and

Q.sub.2 is optionally substituted with up to 4 substituents, independently selected from halo; C.sub.1 -C.sub.3 alkyl; C.sub.1 -C.sub.3 alkyl substituted with NR', OR', CO.sub.2 R' or CONR'.sub.2 ; O--(C.sub.1 -C.sub.3)-alkyl; O--(C.sub.1 -C.sub.3)-alkyl substituted with NR', OR', CO.sub.2 R' or CONR'.sub.2 ; NR'.sub.2 ; OCF.sub.3 ; CF.sub.3 ; NO.sub.2 ; CO.sub.2 R'; CONR'; SR'; SCF.sub.3 ; or CN;

wherein R' is selected from hydrogen, (C.sub.1 -C.sub.3)-alkyl or (C.sub.2 -C.sub.3)-alkenyl or alkynyl;

X is selected from --S--, --O--, --S(O.sub.2)--, --S(O)--, --S(O.sub.2)--N(R)--, --N (R) --S(O.sub.2)--, --N(R)--C(O)O--, --O--C(O)--N(R)--, --C(O)--, --C(O)O--, --O--C(O)--, --C(O)--N(R)--, --N(R) --C(O)--, --N(R)--, or --C(R.sub.2)--;

each R is independently selected from hydrogen, --R.sup.2, --NR.sup.2.sub.2, --OR.sup.2, SR.sup.2, --C(O)--NR.sup.2.sub.2 or --C(O)--OR.sup.2 wherein two adjacent R are optionally bound to one another and, together with each Y to which they are respectively bound, form a 4-8 membered carbocyclic or heterocyclic ring;

R.sup.2 is selected from hydrogen, (C.sub.1 -C.sub.3)-alkyl, O--(C.sub.2 -C.sub.3)-alkyl, (C.sub.1 -C.sub.3)-alkenyl or O--C(C.sub.2 -C.sub.3)-alkenyl, each optionally substituted with W;

W is selected from --N(R').sub.2, --OR', --SR', --S(O)R', --S(O.sub.2)R', C(O)OR', ##STR39## or any 5 to 7-membered heterocyclic ring comprising up to 3 heteroatoms independently selected from N, O or S, wherein said heterocyclic ring is optionally substituted with up to 3 substituents independently selected from halo, C.sub.1 -C.sub.3 alkyl, O--(C.sub.1 -C.sub.3)-alkyl, NR'.sub.2, OCF.sub.3, CF.sub.3, NO.sub.2, CO.sub.2 R', CONR' or CN;

Y is C;

A is N;

n is 1 and

R.sub.1 is selected from hydrogen, (C.sub.1 -C.sub.3)-alkyl, OH, or O--(C.sub.1 -C.sub.3)-alkyl.

2. The compound according to claim 1, wherein Q.sub.1 is selected from phenyl or pyridyl containing 1 to 3 substituents independently selected from chloro, fluoro, bromo, --CH.sub.3, --OCH.sub.3, --OH, --CF.sub.3, --OCF.sub.3, --O(CH.sub.2).sub.2 CH.sub.3 or NH.sub.2, and wherein at least one of said substituents is in the ortho position and said substituents are independently selected from chloro, fluoro, bromo, --CH.sub.3, --OCH.sub.3, --OH, --CF.sub.3, --OCF.sub.3, --O(CH.sub.2).sub.2 CH.sub.3 or NH.sub.2.

3. The compound according to claim 2, wherein Q.sub.1 contains at least two substituents, both of which are in the ortho position.

4. The compound according to claim 2, wherein Q.sub.1 is selected from: ##STR40##

5. The compound according to claim 3, wherein Q.sub.1 is selected from 2,6-difluorophenyl or 2,6-dichlorophenyl.

6. The compound according to claim 1, wherein Q.sub.2 is selected from phenyl or pyridyl and wherein Q.sub.2 optionally contains up to 3 substituents, each of which is independently selected from chloro, fluoro, methyl, --OCH.sub.3, --OH, --NH.sub.2, --CF.sub.3, --OCF.sub.3, --SCH.sub.3, --OCH.sub.3, --C(O)OH and --CH.sub.2 CH.sub.2 OH.

7. The compound according to claim 6, wherein, Q.sub.2 is selected from: or unsubstituted phenyl.

8. The compund according to claim 7, wherein Q.sub.2 is selected from phenyl or 4-fluorophenyl.

9. The compound according to claim 1, wherein X is selected from --S--, --O--, --S(O.sub.2)--, --S(0)--, --NR--, --C(R.sub.2)-- or --C(O)--.

10. The compound according to claim 9, wherein X is S.

11. The compound according to claim 1, wherein each R attached to Y is independently selected from hydrogen or methyl.

12. The compound according to claim 11, having formula: ##STR41## and being selected from the compounds indicated in the table below:

    ______________________________________
    Cmpd# Q.sub.1      Q.sub.2    R.sub.a
                                         R.sub.b
    ______________________________________
    2     4-fluorophenyl
                       phenyl     hydrogen
                                         hydrogen
    3     2,4-dichlorophenyl
                       phenyl     hydrogen
                                         hydrogen
    5     2,4-dichlorophenyl
                       4-methylphenyl
                                  hydrogen
                                         hydrogen
    6     2,6-dichlorophenyl
                       phenyl     hydrogen
                                         hydrogen
    7     2-chlorophenyl
                       phenyl     hydrogen
                                         hydrogen
    8     2-methylphenyl
                       phenyl     hydrogen
                                         hydrogen
    9     3,4-dichlorophenyl
                       phenyl     hydrogen
                                         hydrogen
    10    4-methoxyphenyl
                       phenyl     hydrogen
                                         hydrogen
    11    2-methoxyphenyl
                       phenyl     hydrogen
                                         hydrogen
    12    2,6-dichlorophenyl
                       4-fluorophenyl
                                  hydrogen
                                         hydrogen
    13    2,6-dichlorophenyl
                       phenyl     methyl methyl
    14    2,6-dichlorophenyl
                       4-methylphenyl
                                  hydrogen
                                         hydrogen
    15    2,6-dichlorophenyl
                       3-methlyphenyl
                                  hydrogen
                                         hydrogen
    16    2,6-dichlorophenyl
                       3,4-       hydrogen
                                         hydrogen.
                       dichlorophenyl
    ______________________________________


13. A pharmaceutical composition comprising an amount of a compound according to any one of claims 1 to 12 effective to inhibit p 38, and a pharmaceutcially acceptable carrier.

14. A method of treating or preventing inflammatory disease, autoimmune disease, destructive bone disorder, proliferative disorder, infectious disease, viral disease, or neurodegenerative disease in a pateint, said method comprising administering to said patient a composition according to claim 13.

15. The method according to claim 14, wherein said method is used to treat or prevent an inflammatory disease selected from acute pancreatitis, chronic pancreatitis, asthma, allergies, or adult respiratory distress syndrome.

16. The method according to claim 14, wherein said method is used to treat or prevent an autoimmune disease selected from glomeralonephritis, rheumatoid arthritis, systemic lupus erythematosus, scleroderma, chronic thyroiditis, Graves' disease, autoimmune gastritis, insulin-dependent diabetes mellitus (Type I), autoimmune hemolytic anemia, autoimmune neutropenia, thrombocytopenia, atopic dermatitis, chronic active hepatitis, myasthenia gravis, multiple sclerosis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, psoriasis, or graft vs. host disease.

17. The method according to claim 14, wherein said method is used to treat or prevent a destructive bone disorders selected from osteoarthritis, osteoporosis or multiple myeloma-related bone disorder.

18. The method according to claim 14, wherein said method is used to treat or prevent a proliferative disease selected from acute myelogenous leukemia, chronic myelogenous leukemia, metastatic melanoma, Kaposi's sarcoma, or multiple myeloma.

19. The method according to claim 14, wherein said method is used to treat or prevent an infectious disease selected from sepsis, septic shock, or Shigellosis.

20. The method according to claim 14, wherein said method is used to treat or prevent a viral disease selected from acute hepatitis infection, HIV infection or CMV retinitis.

21. The method according to claim 14, wherein said method is used to treat or prevent a neurodegenerative disease selected from Alzheimer's disease, Parkinson's disease or cerebral ischemia.

22. A method of treating or preventing ischemia/reperfusion in stroke, or myocardial ischemia, renal ischemia, heart attacks, organ hypoxia or thrombin-induced platelet aggregation in a patient, said method comprising the step of administering to said patient a pharmaceutical composition according to claim 12.

23. A method of inhibiting prostaglandin endoperoxide synthase-2 in a patient, comprising the step of administering to said patient a pharmaceutical composition according to claim 12.

24. The method according to claim 23, wherein said method is used to treat or prevent edema, fever, analgesia or to manage pain.

25. The method according to claim 24, wherein said pain is selected from neuromuscular pain, headache, cancer pain, dental pain or arthritis pain.

logo
Tipping rack for bottle

Calibration of magnetic tape drive

Liquid crystal display device

Locking hole punch

Steering system for vehicles

1,3,4-Thiadiazines

Angularly adjustable snowboard binding mount

Vehicle seat air bag arrangement

Cosmetic firming formulation

Method of making field emitters

Coal carbonization and/or gasification plant

Card holding device

Signal reproducing circuit

Circuit interlock arrangement

Multi-dimensional sound reproduction system

Positioning controller

Backwashing-type filtering apparatus

Immunoassay for phencyclidine

Tube couplings

Diet control device and method

Synchronous coupling

Locking device

Modified asphalt hydraulic sealer

Power operated toothbrush

Display device

Swine feeding apparatus

Lifting mechanism

Composite membranes for fluid separations

Structure of angular rate sensor

Wireless telecommunication digital receiver

Inorganic binders employing waste glass

Automatic insulating tape wrapping apparatus

Flexible textile spindle assembly

Process for preparing polyolefins

Withstand-voltage tire

Method for producing resist structures

Droppable airborne buoy

Ergonomic arm support

Device for use in diagnosis

Compressible packages for infusible substances

Wireless control device

Iodine adsorbent

Step controller

Clip

Tubular grafts from purified submucosa

Internal combustion engine

Power-off brake with manual release

Mouse support

Wind energy conversion device

Radiating device for hyperthermia

Tapered electrode for stacked capacitors

Combine header grain catch pans

Distributed crossbar switch architecture

Base for roadway marker

Paraffin ammoxidation process

Acoustic hit indicator

Flexible pipe joint system

Apparatus for opening envelopes

Suspension mechanism for tracked vehicles

Compact electric asymmetry brake

Primer compositions

Papermaking belt having reinforcing piles

Certain 5,6-dihydro-prostacyclin analogs

Electrical circuit tester

Extended moment arm anti-spin device

Image recording apparatus

Handle bag of plastic film

Memory protection circuit

Nozzle inner radius inspection system

Bandanna for pets

Hammer drills for making boreholes

Drill pipe tong retaining apparatus

Cord adjusters

Rapid exit herringbone stall

Programmable operator's console

High-pressure discharge lamp

Luggage

Wrap-back test system and method

Singulator for document feeder

Phase shift demodulator

Air-fuel ratio controller

Steam generator arrangement

Automotive air conditioner

Keypad scanning security system

Yarn texturing nozzle

Model house

N,N'-bis-[(.beta.-hydroxy-.beta.-phenyl)-ethyl]-polymethylenediamines and salts thereof

Memory access optimizing method

Overdenture attachment system